ESC 365 - Does serum 25-hydroxyvitamin D levels have impacts on sarcopenia in patients with chronic heart failure?

EAPC Premium Access

Does serum 25-hydroxyvitamin D levels have impacts on sarcopenia in patients with chronic heart failure?

Session: Moderated posters session 2 - Secondary Prevention and Rehabilitation

Topic: Rehabilitation

Speaker: Mr R. Nagaoka (Sapporo, JP)

Event: ESC Preventive Cardiology 2022

Congress Presentation

Add to my library

About the speaker

Mr Ryohei Nagaoka

Sapporo Medical University Hospital, Sapporo (Japan)

0 follower

4 more presentations in this session

Exergaming in cardiac rehabilitation: a systematic review and meta-analysis

Speaker: Mr C. Blasco-Peris (Alicante, ES)

Rehabilitation of the unmotivated: remote cardiac rehabilitation among patients of all risk levels who reported unwillingness to participate in hospital-based rehabilitation

Speaker: Mr D. Breitner (IL)

Virtual cardiac rehabilitation during the COVID-19 pandemic: a tertiary site experience

Speaker: Doctor N. Moulson (Vancouver, CA)

An artificial intelligence model to predict 12-month mortality among patients with myocardial infarction

Speaker: Mrs A. Hovornyan (Chernivtsi, UA)

Access the full session

Moderated posters session 2 - Secondary Prevention and Rehabilitation

Speakers: Mr R. Nagaoka, Mr C. Blasco-Peris, Mr D. Breitner, Doctor N. Moulson, Mrs A. Hovornyan

About the event

ESC Preventive Cardiology 2022

7 April - 9 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources